Clinical Trial Update: Pyridostigmine for the Treatment of Constipation in Parkinson Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pyridostigmine for constipation in Parkinson disease is currently recruiting. The study is led by the University of Vermont …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Parkinson Disease

Drugs mentioned

• Pyridostigmine (pyridostigmine)

Snippet

Sponsor: University of Vermont Medical Center | Conditions: Parkinson Disease, Constipation | Phase 2 | Status: RECRUITING